ADMA Biologics ADMA Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's accounts receivable?
- ADMA Biologics (ADMA) reported accounts receivable of $135.86M in Q1 2026.
- How has ADMA Biologics's accounts receivable changed year-over-year?
- ADMA Biologics's accounts receivable increased by 36.7% year-over-year, from $99.41M to $135.86M.
- What is the long-term trend for ADMA Biologics's accounts receivable?
- Over 5 years (2020 to 2025), ADMA Biologics's accounts receivable has grown at a 64.3% compound annual growth rate (CAGR), from $13.24M to $158.43M.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.